3.連結財務諸表及び主な注記

(1)連結貸借対照表

 

 

 

 

 

 

 

 

 

 

 

(単位:百万円)

 

 

 

 

 

 

 

 

 

 

前連結会計年度

(2024年3月31日)

当連結会計年度

(2025年3月31日)

資産の部

 

 

 

流動資産

 

 

 

 

現金及び預金

99,667

106,668

 

 

受取手形及び売掛金

160,240

166,858

 

 

契約資産

-

226

 

 

商品及び製品

150,391

170,857

 

 

仕掛品

20,757

21,105

 

 

原材料及び貯蔵品

55,915

59,149

 

 

その他

42,555

56,317

 

 

貸倒引当金

5,362

6,764

 

 

流動資産合計

524,166

574,418

 

固定資産

 

 

 

 

有形固定資産

 

 

 

 

 

建物及び構築物

337,409

350,245

 

 

 

 

減価償却累計額及び減損損失累計額

156,680

171,399

 

 

 

 

建物及び構築物(純額)

180,729

178,845

 

 

 

機械装置及び運搬具

408,015

459,621

 

 

 

 

減価償却累計額及び減損損失累計額

288,780

326,411

 

 

 

 

機械装置及び運搬具(純額)

119,235

133,210

 

 

 

土地

47,061

48,288

 

 

 

リース資産

40,149

45,298

 

 

 

 

減価償却累計額

16,778

20,679

 

 

 

 

リース資産(純額)

23,371

24,619

 

 

 

建設仮勘定

83,284

88,975

 

 

 

その他

101,983

113,597

 

 

 

 

減価償却累計額及び減損損失累計額

74,156

83,709

 

 

 

 

その他(純額)

27,826

29,887

 

 

 

有形固定資産合計

481,508

503,827

 

 

無形固定資産

 

 

 

 

 

のれん

15,607

14,099

 

 

 

リース資産

1,921

1,880

 

 

 

その他

17,609

19,525

 

 

 

無形固定資産合計

35,138

35,505

 

 

投資その他の資産

 

 

 

 

 

投資有価証券

32,945

15,287

 

 

 

退職給付に係る資産

94

2,278

 

 

 

繰延税金資産

13,116

17,216

 

 

 

その他

29,990

27,842

 

 

 

貸倒引当金

7,139

5,814

 

 

 

投資その他の資産合計

69,007

56,812

 

 

固定資産合計

585,655

596,145

 

資産合計

1,109,821

1,170,564

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(単位:百万円)

 

 

 

 

 

 

 

 

 

 

前連結会計年度

(2024年3月31日)

当連結会計年度

(2025年3月31日)

負債の部

 

 

 

流動負債

 

 

 

 

支払手形及び買掛金

81,502

83,802

 

 

短期借入金

160,367

156,174

 

 

コマーシャル・ペーパー

20,000

-

 

 

1年内償還予定の社債

4,700

1,000

 

 

リース債務

4,748

6,653

 

 

未払金

25,837

30,979

 

 

未払法人税等

6,125

5,922

 

 

契約負債

714

1,035

 

 

賞与引当金

11,436

9,058

 

 

設備関係支払手形

5,591

4,799

 

 

その他

45,451

51,119

 

 

流動負債合計

366,475

350,545

 

固定負債

 

 

 

 

社債

82,000

103,000

 

 

転換社債型新株予約権付社債

30,150

30,090

 

 

長期借入金

302,819

309,987

 

 

リース債務

25,312

25,170

 

 

繰延税金負債

1,619

2,018

 

 

退職給付に係る負債

5,675

7,244

 

 

役員退職慰労引当金

557

584

 

 

訴訟損失引当金

227

276

 

 

その他

25,195

30,024

 

 

固定負債合計

473,557

508,397

 

負債合計

840,032

858,942

純資産の部

 

 

 

株主資本

 

 

 

 

資本金

84,397

84,397

 

 

資本剰余金

0

-

 

 

利益剰余金

104,321

104,783

 

 

自己株式

10,749

10,749

 

 

株主資本合計

177,970

178,431

 

その他の包括利益累計額

 

 

 

 

その他有価証券評価差額金

9,704

2,741

 

 

繰延ヘッジ損益

50

176

 

 

為替換算調整勘定

43,516

68,920

 

 

退職給付に係る調整累計額

1,524

2,172

 

 

その他の包括利益累計額合計

54,695

74,010

 

新株予約権

-

4

 

非支配株主持分

37,123

59,175

 

純資産合計

269,788

311,621

負債純資産合計

1,109,821

1,170,564

 

E02688 80860 ニプロ株式会社 NIPRO CORPORATION 通期第1号参考様式 [日本基準](連結) Japan GAAP true cte cte 2024-04-01 2025-03-31 FY 2025-03-31 2023-04-01 2024-03-31 2024-03-31 1 false false false 80860 2025-05-12 80860 2024-04-01 2025-03-31 80860 2024-04-01 2025-03-31 jppfs_cor:CapitalStockMember 80860 2024-04-01 2025-03-31 jppfs_cor:CapitalSurplusMember 80860 2024-04-01 2025-03-31 jppfs_cor:DeferredGainsOrLossesOnHedgesMember 80860 2024-04-01 2025-03-31 jppfs_cor:ForeignCurrencyTranslationAdjustmentMember 80860 2024-04-01 2025-03-31 jppfs_cor:NonControllingInterestsMember 80860 2024-04-01 2025-03-31 jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember 80860 2024-04-01 2025-03-31 jpcrp_cor:ReconcilingItemsMember 80860 2024-04-01 2025-03-31 jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember 80860 2024-04-01 2025-03-31 jpcrp_cor:ReportableSegmentsMember 80860 2024-04-01 2025-03-31 jppfs_cor:RetainedEarningsMember 80860 2024-04-01 2025-03-31 jppfs_cor:ShareholdersEquityMember 80860 2024-04-01 2025-03-31 jppfs_cor:SubscriptionRightsToSharesMember 80860 2024-04-01 2025-03-31 jpcrp_cor:TotalOfReportableSegmentsAndOthersMember 80860 2024-04-01 2025-03-31 jppfs_cor:TreasuryStockMember 80860 2024-04-01 2025-03-31 tse-acedjpfr-80860:MedicalTreatmentRelatedReportableSegmentsMember 80860 2024-04-01 2025-03-31 tse-acedjpfr-80860:MedicineRelatedReportableSegmentsMember 80860 2024-04-01 2025-03-31 tse-acedjpfr-80860:PharmaPackagingReportableSegmentMember 80860 2024-04-01 2025-03-31 jppfs_cor:ValuationAndTranslationAdjustmentsMember 80860 2024-04-01 2025-03-31 jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember 80860 2025-03-31 80860 2025-03-31 jppfs_cor:CapitalStockMember 80860 2025-03-31 jppfs_cor:CapitalSurplusMember 80860 2025-03-31 jppfs_cor:DeferredGainsOrLossesOnHedgesMember 80860 2025-03-31 jppfs_cor:ForeignCurrencyTranslationAdjustmentMember 80860 2025-03-31 jppfs_cor:NonControllingInterestsMember 80860 2025-03-31 jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember 80860 2025-03-31 jpcrp_cor:ReconcilingItemsMember 80860 2025-03-31 jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember 80860 2025-03-31 jpcrp_cor:ReportableSegmentsMember 80860 2025-03-31 jppfs_cor:RetainedEarningsMember 80860 2025-03-31 jppfs_cor:ShareholdersEquityMember 80860 2025-03-31 jppfs_cor:SubscriptionRightsToSharesMember 80860 2025-03-31 jpcrp_cor:TotalOfReportableSegmentsAndOthersMember 80860 2025-03-31 jppfs_cor:TreasuryStockMember 80860 2025-03-31 tse-acedjpfr-80860:MedicalTreatmentRelatedReportableSegmentsMember 80860 2025-03-31 tse-acedjpfr-80860:MedicineRelatedReportableSegmentsMember 80860 2025-03-31 tse-acedjpfr-80860:PharmaPackagingReportableSegmentMember 80860 2025-03-31 jppfs_cor:ValuationAndTranslationAdjustmentsMember 80860 2025-03-31 jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember 80860 2023-04-01 2024-03-31 80860 2023-04-01 2024-03-31 jppfs_cor:CapitalStockMember 80860 2023-04-01 2024-03-31 jppfs_cor:CapitalSurplusMember 80860 2023-04-01 2024-03-31 jppfs_cor:DeferredGainsOrLossesOnHedgesMember 80860 2023-04-01 2024-03-31 jppfs_cor:ForeignCurrencyTranslationAdjustmentMember 80860 2023-04-01 2024-03-31 jppfs_cor:NonControllingInterestsMember 80860 2023-04-01 2024-03-31 jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember 80860 2023-04-01 2024-03-31 jpcrp_cor:ReconcilingItemsMember 80860 2023-04-01 2024-03-31 jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember 80860 2023-04-01 2024-03-31 jpcrp_cor:ReportableSegmentsMember 80860 2023-04-01 2024-03-31 jppfs_cor:RetainedEarningsMember 80860 2023-04-01 2024-03-31 jppfs_cor:ShareholdersEquityMember 80860 2023-04-01 2024-03-31 jppfs_cor:SubscriptionRightsToSharesMember 80860 2023-04-01 2024-03-31 jpcrp_cor:TotalOfReportableSegmentsAndOthersMember 80860 2023-04-01 2024-03-31 jppfs_cor:TreasuryStockMember 80860 2023-04-01 2024-03-31 tse-acedjpfr-80860:MedicalTreatmentRelatedReportableSegmentsMember 80860 2023-04-01 2024-03-31 tse-acedjpfr-80860:MedicineRelatedReportableSegmentsMember 80860 2023-04-01 2024-03-31 tse-acedjpfr-80860:PharmaPackagingReportableSegmentMember 80860 2023-04-01 2024-03-31 jppfs_cor:ValuationAndTranslationAdjustmentsMember 80860 2023-04-01 2024-03-31 jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember 80860 2024-03-31 80860 2024-03-31 jppfs_cor:CapitalStockMember 80860 2024-03-31 jppfs_cor:CapitalSurplusMember 80860 2024-03-31 jppfs_cor:DeferredGainsOrLossesOnHedgesMember 80860 2024-03-31 jppfs_cor:ForeignCurrencyTranslationAdjustmentMember 80860 2024-03-31 jppfs_cor:NonControllingInterestsMember 80860 2024-03-31 jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember 80860 2024-03-31 jpcrp_cor:ReconcilingItemsMember 80860 2024-03-31 jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember 80860 2024-03-31 jpcrp_cor:ReportableSegmentsMember 80860 2024-03-31 jppfs_cor:RetainedEarningsMember 80860 2024-03-31 jppfs_cor:ShareholdersEquityMember 80860 2024-03-31 jppfs_cor:SubscriptionRightsToSharesMember 80860 2024-03-31 jpcrp_cor:TotalOfReportableSegmentsAndOthersMember 80860 2024-03-31 jppfs_cor:TreasuryStockMember 80860 2024-03-31 tse-acedjpfr-80860:MedicalTreatmentRelatedReportableSegmentsMember 80860 2024-03-31 tse-acedjpfr-80860:MedicineRelatedReportableSegmentsMember 80860 2024-03-31 tse-acedjpfr-80860:PharmaPackagingReportableSegmentMember 80860 2024-03-31 jppfs_cor:ValuationAndTranslationAdjustmentsMember 80860 2024-03-31 jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember 80860 2022-04-01 2023-03-31 80860 2022-04-01 2023-03-31 jppfs_cor:CapitalStockMember 80860 2022-04-01 2023-03-31 jppfs_cor:CapitalSurplusMember 80860 2022-04-01 2023-03-31 jppfs_cor:DeferredGainsOrLossesOnHedgesMember 80860 2022-04-01 2023-03-31 jppfs_cor:ForeignCurrencyTranslationAdjustmentMember 80860 2022-04-01 2023-03-31 jppfs_cor:NonControllingInterestsMember 80860 2022-04-01 2023-03-31 jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember 80860 2022-04-01 2023-03-31 jppfs_cor:RetainedEarningsMember 80860 2022-04-01 2023-03-31 jppfs_cor:ShareholdersEquityMember 80860 2022-04-01 2023-03-31 jppfs_cor:SubscriptionRightsToSharesMember 80860 2022-04-01 2023-03-31 jppfs_cor:TreasuryStockMember 80860 2022-04-01 2023-03-31 jppfs_cor:ValuationAndTranslationAdjustmentsMember 80860 2022-04-01 2023-03-31 jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember 80860 2023-03-31 80860 2023-03-31 jppfs_cor:CapitalStockMember 80860 2023-03-31 jppfs_cor:CapitalSurplusMember 80860 2023-03-31 jppfs_cor:DeferredGainsOrLossesOnHedgesMember 80860 2023-03-31 jppfs_cor:ForeignCurrencyTranslationAdjustmentMember 80860 2023-03-31 jppfs_cor:NonControllingInterestsMember 80860 2023-03-31 jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember 80860 2023-03-31 jppfs_cor:RetainedEarningsMember 80860 2023-03-31 jppfs_cor:ShareholdersEquityMember 80860 2023-03-31 jppfs_cor:SubscriptionRightsToSharesMember 80860 2023-03-31 jppfs_cor:TreasuryStockMember 80860 2023-03-31 jppfs_cor:ValuationAndTranslationAdjustmentsMember 80860 2023-03-31 jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember iso4217:JPY xbrli:pure